Geopolitical tensions top life sciences sector’s economic risks, Willis report says
WTW•Geopolitical tensions rank as the life sciences industry’s top economic risk in a Willis Towers Watson report. US drug pricing and payment reforms rank second.
1. Industry risk rankings
Geopolitical tensions rank as the life sciences industry’s top economic risk in Willis Towers Watson’s Nov. 5, 2026, report, with restrictions potentially limiting access to markets, suppliers and research partners. US drug pricing and payment reforms rank second, while regulatory divergence, tariff volatility and rising healthcare costs are also concerns.
